REG - hVIVO plc - Directorate Change
RNS Number : 7019LhVIVO plc02 January 2019HVIVO PLC
("hVIVO" or the "Company")
Directorate Change
2 January 2019
The Company confirms that, as previously announced, Graham Yeatman ceased to be a Director of hVIVO with effect from 31st December 2018.
Trevor Phillips, Executive Chairman of hVIVO, said: "Along with the rest of the Board, I would like to thank Graham for his many contributions to the Company during the last seven years and we all wish him well in his future endeavours."
For further information please contact:
hVIVO plc
Trevor Phillips (Executive Chairman)
+44 207 756 1300
Fleur Wood (EVP, Investor Relations & Communications)
Numis Securities Limited
+44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
FTI Consulting
Simon Conway / Victoria Foster Mitchell
+44 203 727 1000
About hVIVO:
hVIVO plc ("hVIVO") is pioneering a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases. Leveraging human disease models in flu, RSV, HRV and respiratory indications, the hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO has conducted more than 50 clinical studies and inoculated over 2500 volunteers.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDBOADMMZZLRLGRZG
Recent news on hVIVO
See all newsREG - hVIVO PLC - Annual Report & Notice of AGM
AnnouncementREG - hVIVO PLC - Final results
AnnouncementREG - hVIVO PLC - Notice of Results
AnnouncementREG - hVIVO PLC - Holding(s) in Company
AnnouncementRCS - European Green Trans - Intention to float on the AIM market
Announcement